在瘤学中,免疫治疗后的免疫相关不良事件:一般实践指南
Hui-Ling Yeoh1, Karen Freilich2, Mark Voskoboynik3
1MBBS(Hons), BMedSc(Hons), Medical Oncology Clinical Trials Fellow, Department of Medical Oncology, Alfred Hospital, Melbourne, Vic; Clinical Bedside Tutor, Central Clinical School, Monash University, Melbourne, Vic.
癌症免疫疗法已经彻底改变了癌症治疗,但可以引起与免疫相关的不良事件 (irAEs). 早期识别和管理这些副作用对于患者的治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 癌症免疫疗法已经改变了患者在转移和辅助环境中的预后.
- 免疫相关的不良事件 (irAEs) 是常见的,可能是严重的,可以影响任何器官系统.
- 轻度或非特异性的irAE症状可能会延迟诊断和管理,增加发病风险.
研究的目的:
- 提供癌症免疫治疗的全面概述.
- 详细说明与免疫相关的不良事件 (irAEs) 的范围.
- 突出共同的临床表现,并概述对IRAE的一般管理策略.
主要方法:
- 免疫疗法和irAEs的文献综述.
- 综合临床情景和管理原则.
- 基于指导方针的方法来管理irAE.
主要成果:
- 免疫疗法在癌症治疗中提供了显著的好处.
- irAEs带来了相当大的临床挑战,有可能导致严重的并发症.
- 有效的管理需要早期诊断和遵守治疗指南.
结论:
- 癌症免疫疗法毒性在一般实践中越来越令人担忧.
- 及时识别和干预是缓解irAE严重性的关键.
- 一般医生和瘤团队之间的协作管理对于最佳的患者护理至关重要.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
相关概念视频
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Allergic Drug Reactions
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
